Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

240
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
240
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

218
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
218
Qualitative Analysis03:46

Qualitative Analysis

22.4K
For solutions containing mixtures of different cations, the identity of each cation can be determined by qualitative analysis. This technique involves a series of selective precipitations with different chemical reagents, each reaction producing a characteristic precipitate for a specific group of cations. Metal ions within a group are further separated by varying the pH, heating the mixture to redissolve a precipitate, or adding other reagents to form complex ions.
For instance, group IV...
22.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Immune dysregulation in the prostates of C57BL/6<sup>Aire-/-</sup> mice mirrors that seen in human benign prostatic hyperplasia.

The Journal of pathology·2026
Same journal

Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of '-mabs'?

The Journal of pathology·2026
Same journal

Bronchiolar adenoma-like lesions with atypical features beyond the classic morphological spectrum: integrating histomorphology and molecular profiles.

The Journal of pathology·2026
Same journal

Differences between mitotically old and young endometrial tumors.

The Journal of pathology·2026
Same journal

Knowledge gaps in tubular gut tumours: a critical appraisal of the 6th edition of the World Health Organization classification of tumours.

The Journal of pathology·2026
Same journal

Tumor Invasive Border Index (TIBI) in colorectal cancer: linking infiltrative morphology to molecular insights.

The Journal of pathology·2026

Related Experiment Video

Updated: Jul 26, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.7K

An acid test for metformin†.

Don Benjamin1

  • 1Biozentrum, University of Basel, Basel, Switzerland.

The Journal of Pathology
|June 16, 2023
PubMed
Summary
This summary is machine-generated.

Syrosingopine and metformin show a synergistic effect in killing multiple myeloma cells. This combination therapy, targeting lactate transport, offers a promising new avenue for cancer treatment.

Keywords:
cancerdrug repurposingmetforminsyrosingopine

More Related Videos

Measuring Mitochondrial Substrate Flux in Recombinant Perfringolysin O-Permeabilized Cells
06:17

Measuring Mitochondrial Substrate Flux in Recombinant Perfringolysin O-Permeabilized Cells

Published on: August 13, 2021

2.5K
An Optimized Protocol to Analyze Glycolysis and Mitochondrial Respiration in Lymphocytes
08:40

An Optimized Protocol to Analyze Glycolysis and Mitochondrial Respiration in Lymphocytes

Published on: November 21, 2016

29.9K

Related Experiment Videos

Last Updated: Jul 26, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.7K
Measuring Mitochondrial Substrate Flux in Recombinant Perfringolysin O-Permeabilized Cells
06:17

Measuring Mitochondrial Substrate Flux in Recombinant Perfringolysin O-Permeabilized Cells

Published on: August 13, 2021

2.5K
An Optimized Protocol to Analyze Glycolysis and Mitochondrial Respiration in Lymphocytes
08:40

An Optimized Protocol to Analyze Glycolysis and Mitochondrial Respiration in Lymphocytes

Published on: November 21, 2016

29.9K

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Highly glycolytic cancer cells rely on lactic acid export for homeostasis.
  • Monocarboxylate transporters (MCTs), specifically MCT1 and MCT4, are key in this process.
  • Syrosingopine inhibits MCT1 and MCT4, presenting a potential therapeutic target.

Purpose of the Study:

  • To investigate the combined therapeutic effect of syrosingopine and metformin on multiple myeloma (MM).
  • To evaluate the synergistic potential of targeting lactate transport in cancer cells.

Main Methods:

  • Utilized cultured multiple myeloma cell lines.
  • Tested the drug combination on primary MM blasts from patients.
  • Employed a mouse model of multiple myeloma.

Main Results:

  • Syrosingopine and metformin demonstrated a synergistic effect in killing MM cells.
  • The combination therapy was effective against both cultured cell lines and patient-derived primary cells.
  • The synergistic effect was also observed in a preclinical mouse model of MM.

Conclusions:

  • The combination of syrosingopine and metformin exhibits synthetic lethality in multiple myeloma.
  • These drugs, with established safety profiles, offer a potential clinical strategy for anticancer therapy.
  • Targeting lactate transport via MCT inhibition presents a viable therapeutic approach for multiple myeloma.